Related Experiment Video
Updated: Aug 15, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Constipation and meconium ileus equivalent in patients with cystic fibrosis
Insights
Constipation and meconium ileus equivalent are common in cystic fibrosis patients. Early, aggressive treatment can prevent complications and recurrences in individuals with cystic fibrosis.
Area of Science:
- Gastroenterology
- Pediatrics
- Pulmonology
Background:
- Cystic fibrosis (CF) management involves addressing gastrointestinal complications.
- Constipation and meconium ileus equivalent (MIE) pose significant challenges in CF patients.
Observation:
- A retrospective review analyzed 168 CF patients' medical records.
- Prevalence of constipation and MIE was assessed in relation to age and clinical history.
Findings:
- 32% of patients experienced constipation, responding to laxative therapy.
- 9% of patients developed meconium ileus equivalent.
- Higher prevalence of both conditions was observed in patients over 30 years old, while younger than 5 had lower prevalence.
- Inadequately controlled steatorrhea was linked to increased MIE risk.
Implications:
- Early and proactive management of constipation is crucial in CF.
- Aggressive therapeutic strategies may prevent MIE development and recurrence.
- Understanding risk factors like steatorrhea can guide preventative care in cystic fibrosis.
Abstract:
Constipation and its complications, particularly meconium ileus equivalent, may become management problems in patients with cystic fibrosis. The medical records of 168 patients with cystic fibrosis were reviewed for the prevalence of constipation and meconium ileus equivalent. Of 168 patients, 54 (32%) had experienced at least one episode of constipation which responded to oral or rectal laxative therapy. In 16 of the study group (9%) meconium ileus equivalent developed. Patients younger than 5 years of age had a lower prevalence and those older than 30 years of age had a much higher prevalence of both conditions. Those with prolonged histories of inadequately controlled steatorrhea appeared to be at higher risk for the eventual development of meconium ileus equivalent. Recurrences and complications of constipation may be avoided by instituting early and aggressive therapy.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Drugs for Treatment of Constipation-Predominant IBS
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Lower GI Series: Barium Enema
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
Intestinal Obstruction I: Introduction
Intestinal Obstruction II: Pathophysiology

